Globus Medical (GMED) said Wednesday it expects Q4 sales of about $657 million, up from $616.5 million a year earlier.
Analysts polled by FactSet expect $635.5 million.
The company said 2024 sales are expected to be about $2.52 billion.
Analysts surveyed by FactSet expect $2.5 billion.
Globus expects 2025 revenue of $2.66 billion to $2.69 billion and diluted non-GAAP earnings of $3.40 to $3.50 a share.
Analysts polled by FactSet expect revenue of $2.66 billion and EPS of $3.42.
Globus shares rose 2.8% in recent after-hours trading.
Price: 89.00, Change: +2.45, Percent Change: +2.83
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。